SCOPUS 정보 검색 플랫폼

Clinical and Translational Science

Volumn 1, Issue 3, 2008, Pages 263-264

Cytokine adjuvanation of therapeutic anti-tumor immunity targeted to cancer mucosa antigens

(5) Snook, Adam E a Huang, Lan b Schulz, Stephanie a Eisenlohr, Laurence C b Waldman, Scott A a

a THOMAS JEFFERSON UNIVERSITY (United States)

b THOMAS JEFFERSON UNIVERSITY (United States)

Author keywords

Cancer immunotherapy; Cancer mucosa antigens; Colorectal cancer; GM CSF; Guanylyl cyclase C; IL 2

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GUANYLATE CYCLASE; GUANYLATE CYCLASE C; INTERLEUKIN 2; PLASMID DNA; UNCLASSIFIED DRUG; VIRUS VECTOR;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; COLORECTAL CANCER; CONTROLLED STUDY; DRUG EFFICACY; INTESTINE MUCOSA; LUNG METASTASIS; MONOTHERAPY; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SURVIVAL TIME; TUMOR IMMUNITY; TUMOR VOLUME; VIRUS RECOMBINANT;

ANIMALS; COLORECTAL NEOPLASMS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; GUANYLATE CYCLASE; IMMUNIZATION; INTERLEUKIN-2; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; RECEPTORS, PEPTIDE;

MURINAE;

EID: 77953465549 PISSN: 17528054 EISSN: 17528062 Source Type: Journal
DOI: 10.1111/j.1752-8062.2008.00054.x Document Type: Article

Times cited : (8)

References (10)

1
- 0037381134
- Immunology and immunotherapy of colorectal cancer
- Dalerba P, Maccalli C, Casati C, Castelli C, Parmiani G. Immunology and immunotherapy of colorectal cancer. Crit Rev Oncol Hematol. 2003; 46: 33-57.
- (2003) Crit Rev Oncol Hematol , vol.46 , pp. 33-57
- Dalerba, P.¹ Maccalli, C.² Casati, C.³ Castelli, C.⁴ Parmiani, G.⁵

2
- 34548677817
- Mucosally-restricted antigens as novel immunological targets for anti-tumor therapy
- Snook A, Stafford B, Eisenlohr L, Rothstein J, Waldman S. Mucosally-restricted antigens as novel immunological targets for anti-tumor therapy. Biomarkers in Med. 2007; 1: 187-202.
- (2007) Biomarkers in Med , vol.1 , pp. 187-202
- Snook, A.¹ Stafford, B.² Eisenlohr, L.³ Rothstein, J.⁴ Waldman, S.⁵

3
- 36148966955
- Cancer mucosa antigens as a novel immunotherapeutic class of tumor-associated antigen
- Snook AE, Eisenlohr LC, Rothstein JL, Waldman SA. Cancer mucosa antigens as a novel immunotherapeutic class of tumor-associated antigen. Clin Pharmacol Ther. 2007; 82: 734-739.
- (2007) Clin Pharmacol Ther , vol.82 , pp. 734-739
- Snook, A.E.¹ Eisenlohr, L.C.² Rothstein, J.L.³ Waldman, S.A.⁴

4
- 46849089908
- Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity
- Snook AE, Stafford BJ, Li P, Tan G, Huang L, Birbe R, Schulz S, Schnell MJ, Thakur M, Rothstein JL, Eisenlohr LC, Waldman SA. Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity. J Natl Cancer Inst. 2008; 100: 950-961.
- (2008) J Natl Cancer Inst , vol.100 , pp. 950-961
- Snook, A.E.¹ Stafford, B.J.² Li, P.³ Tan, G.⁴ Huang, L.⁵ Birbe, R.⁶ Schulz, S.⁷ Schnell, M.J.⁸ Thakur, M.⁹ Rothstein, J.L.¹⁰ Eisenlohr, L.C.¹¹ Waldman, S.A.¹²

5
- 0029884292
- Improved immunotherapy of a recombinant carcinoembryonic antigen vaccinia vaccine when given in combination with interleukin-2
- McLaughlin JP, Schlom J, Kantor JA, Greiner JW. Improved immunotherapy of a recombinant carcinoembryonic antigen vaccinia vaccine when given in combination with interleukin-2. Cancer Res. 1996; 56: 2361-2367
- (1996) Cancer Res , vol.56 , pp. 2361-2367
- McLaughlin, J.P.¹ Schlom, J.² Kantor, J.A.³ Greiner, J.W.⁴

6
- 0034551730
- Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses
- Marshall JL, Hoyer RJ, Toomey MA, Faraguna K, Chang P, Richmond E, Pedicano JE, Gehan E, Peck RA, Arlen P, Tsang KY, Schlom J. Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses. J Clin Oncol. 2000; 18: 3964-3973.
- (2000) J Clin Oncol , vol.18 , pp. 3964-3973
- Marshall, J.L.¹ Hoyer, R.J.² Toomey, M.A.³ Faraguna, K.⁴ Chang, P.⁵ Richmond, E.⁶ Pedicano, J.E.⁷ Gehan, E.⁸ Peck, R.A.⁹ Arlen, P.¹⁰ Tsang, K.Y.¹¹ Schlom, J.¹²

7
- 0037108688
- Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity
- Aarts WM, Schlom J, Hodge JW. Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity. Cancer Res. 2002; 62: 5770-5777
- (2002) Cancer Res , vol.62 , pp. 5770-5777
- Aarts, W.M.¹ Schlom, J.² Hodge, J.W.³

8
- 34547630506
- A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model
- Ko HJ, Kim YJ, Kim YS, Chang WS, Ko SY, Chang SY, Sakaguchi S, Kang CY. A combination of chemoimmunotherapies can efficiently break self-tolerance and induce antitumor immunity in a tolerogenic murine tumor model. Cancer Res. 2007; 67: 7477-7486.
- (2007) Cancer Res , vol.67 , pp. 7477-7486
- Ko, H.J.¹ Kim, Y.J.² Kim, Y.S.³ Chang, W.S.⁴ Ko, S.Y.⁵ Chang, S.Y.⁶ Sakaguchi, S.⁷ Kang, C.Y.⁸

9
- 33947259319
- Immunosuppressive strategies that are mediated by tumor cells
- Rabinovich GA, Gabrilovich D, Sotomayor EM. Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol. 2007; 25: 267-296.
- (2007) Annu Rev Immunol , vol.25 , pp. 267-296
- Rabinovich, G.A.¹ Gabrilovich, D.² Sotomayor, E.M.³

10
- 33745988889
- Cancer vaccines: Preclinical studies and novel strategies
- Palena C, Abrams SI, Schlom J, Hodge JW. Cancer vaccines: Preclinical studies and novel strategies. Adv Cancer Res. 2006; 95: 115-145.
- (2006) Adv Cancer Res , vol.95 , pp. 115-145
- Palena, C.¹ Abrams, S.I.² Schlom, J.³ Hodge, J.W.⁴

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.